CAR039 Comprehensive Lipid Profile Testing in the Evaluation of ...
CAR039 Comprehensive Lipid Profile Testing in the Evaluation of ...
CAR039 Comprehensive Lipid Profile Testing in the Evaluation of ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Pearson TA, et al: Markers <strong>of</strong> <strong>in</strong>flammation and cardiovascular disease: application to cl<strong>in</strong>ical and<br />
public healt practice. A statement for healhtcare pr<strong>of</strong>essionals from <strong>the</strong> Centers for Disease Control<br />
and Prevention and <strong>the</strong> American Heart Association. Circulation 2003;107:499-511.<br />
Armitage JM, Bowman L, Clarke RJ, et al; Study <strong>of</strong> <strong>the</strong> Effectiveness <strong>of</strong> Additional Reductions <strong>in</strong><br />
Cholesterol and Homocyste<strong>in</strong>e (SEARCH) Collaborative Group. Effects <strong>of</strong> homocyste<strong>in</strong>e-lower<strong>in</strong>g<br />
with folic acid plus vitam<strong>in</strong> B12 vs placebo on mortality and major morbidity <strong>in</strong> myocardial <strong>in</strong>farction<br />
survivors: a randomized trial. JAMA 2010;303:2486–9.<br />
Martí-Carvajal AJ, Sola I, Lathyris D, et al. Homocyste<strong>in</strong>e lower<strong>in</strong>g <strong>in</strong>terventions for prevent<strong>in</strong>g<br />
cardiovascular events. Cochrane Database Syst Rev 2009; 4:CD006612<br />
Iakoubova OA, Sabat<strong>in</strong>e MS, Rowland CM, et al. Polymorphism <strong>in</strong> KIF6 gene and benefit from stat<strong>in</strong>s<br />
after acute coronary syndromes: results from <strong>the</strong> PROVE IT-TIMI 22 study J Am Coll Cardiol<br />
2008;51:449-455<br />
Assimes TL, Hólm H, Kathiresan S, et al. Lack <strong>of</strong> association between <strong>the</strong> Trp719Arg polymorphism<br />
<strong>in</strong> k<strong>in</strong>es<strong>in</strong>-like prote<strong>in</strong>-6 and coronary artery disease <strong>in</strong> 19 case-control studies J Am Coll Cardiol<br />
2010;56:1552-1563<br />
Arsenalt BJ et al. Circ Cardiovasc Genet. 2012 Feb 1;5(1):51-57. Epub 2011 Dec 1.<br />
Expert Panel On Detection, <strong>Evaluation</strong>, And Treatment Of High Blood Cholesterol In Adults (May<br />
2001). "Executive Summary <strong>of</strong> <strong>the</strong> Third Report <strong>of</strong> <strong>the</strong> National Cholesterol Education Program<br />
(NCEP) Expert Panel on Detection, <strong>Evaluation</strong>, and Treatment <strong>of</strong> High Blood Cholesterol <strong>in</strong> Adults<br />
(Adult Treatment Panel III)". JAMA: <strong>the</strong> Journal <strong>of</strong> <strong>the</strong> American Medical Association 285 (19): 2486–<br />
97.<br />
Erqou S, Kaptoge S, Perry PL, Di AE, Thompson A, White IR, Marcov<strong>in</strong>a SM, Coll<strong>in</strong>s R, Thompson<br />
SG, Danesh J. Lipoprote<strong>in</strong>(a) concentration and <strong>the</strong> risk <strong>of</strong> coronary heart disease, stroke, and<br />
nonvascular mortality. JAMA 2009;302:412-423.<br />
Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, et al. Genetically elevated Lipoprote<strong>in</strong> (a) and<br />
<strong>in</strong>creased risk <strong>of</strong> myocardial <strong>in</strong>farction. JAMA 2009; 301:2331-2339.<br />
Isser HS et al. Lipoprote<strong>in</strong> (a) and lipid levels <strong>in</strong> young patients with myocardial <strong>in</strong>farction and <strong>the</strong>ir<br />
first-degree relatives. Indian Heart J. 2001 Jul-Aug;53(4):463-6.<br />
Cardiovascular risk reduction <strong>in</strong> a<strong>the</strong>rogenic dyslipidemia: Beyond LDL-C and stat<strong>in</strong>s. The European<br />
A<strong>the</strong>rosclerosis Society Press Release. Accessed March 2012. http://www.eas-society.org/consensusposition-paper-<strong>in</strong>itiative.aspx<br />
Packard CJ, O'Reilly DS, Caslake MJ et al. Lipoprote<strong>in</strong>-associated phospholipase A2 as an<br />
<strong>in</strong>dependent predictor <strong>of</strong> coronary heart disease. West <strong>of</strong> Scotland Coronary Prevention Study Group.<br />
N Eng J Med 2000;343(16):1148-55.<br />
<strong>Comprehensive</strong> <strong>Lipid</strong> <strong>Pr<strong>of</strong>ile</strong> <strong>Test<strong>in</strong>g</strong> <strong>in</strong> <strong>the</strong> <strong>Evaluation</strong> <strong>of</strong> Cardiovascular Disease Page 13 <strong>of</strong> 14
Change language